Publisher： Adis International
ISSN： 1173-5503
Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.566, 2008-01, pp. : 5-5
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Infliximab, etanercept in RA discussed
Inpharma, Vol. 1, Iss. 1325, 2002-01 ,pp. :
Access to resources
Recommend
Infliximab maintenance therapy valuable strategy in Crohn's disease.
Inpharma, Vol. 1, Iss. 1313, 2001-01 ,pp. :
Rapid improvement in QOL following infliximab in RA
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 494, 2006-01 ,pp. :
Etanercept of greater value than adalimumab or infliximab for RA
Inpharma, Vol. 1, Iss. 1614, 2007-01 ,pp. :
Infliximab enhances methotrexate benefits in early RA
Inpharma, Vol. 1, Iss. 1470, 2005-01 ,pp. :